132 filings
ARS
2024 FY
GOSS
Gossamer Bio Inc
26 Apr 24
Annual report to shareholders
2:20pm
DEFA14A
GOSS
Gossamer Bio Inc
24 Apr 24
Additional proxy soliciting materials
4:02pm
DEF 14A
GOSS
Gossamer Bio Inc
Definitive proxy
24 Apr 24
4:01pm
8-K
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
S-8
GOSS
Gossamer Bio Inc
5 Mar 24
Registration of securities for employees
7:37am
8-K
xq8fhb49nnurc1qv
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
8-K
m1cg pznxocvof
4 Mar 24
Other Events
4:02pm
8-K
ffw08
29 Nov 23
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
4:01pm
8-K
7kh y5u6lfofkur1y
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
fejo 762jkuj
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
8-K
fna1ioy e8pv2wkvyo
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
wxxok
7 Sep 23
Departure of Directors or Certain Officers
5:00pm
EFFECT
xh65jsor
29 Aug 23
Notice of effectiveness
12:15am
424B3
uotk4hl7udjfgsx2c
28 Aug 23
Prospectus supplement
4:29pm
CORRESP
ifrt8sjvcnp6jd6mf7ri
24 Aug 23
Correspondence with SEC
12:00am
UPLOAD
6pkqw38zn6ad dg
24 Aug 23
Letter from SEC
12:00am
S-3
rrjqhdtnmhar9kxjhjqn
18 Aug 23
Shelf registration
8:41am
RW
ub1tgss
18 Aug 23
Registration withdrawal request
8:38am